Request Your Free eBook Now:

"How Biotech can Enhance Patient Engagement in Decentralized Trials with Home Healthcare Solutions"

Eve Kamau, Senior Director, DCT Strategy and Innovation, PPD, Part of Thermo Fisher Scientific

Despite the public’s embrace of clinician home visits as part of general healthcare, clinical trial sponsors have been on a learning curve regarding implementation of home healthcare in clinical trials due to patient safety and data accuracy concerns. Adoption of decentralized clinical trial (DCT) approaches has risen in the past couple of years as an adjunct or alternative to traditional models, especially in cases where sites were inadequately resourced to keep trials running due to various reasons.

Sponsors are increasingly embracing home healthcare due to the benefits, such as reduced burden for clinical trial participants and enhanced patient recruitment, retention, and engagement, and are finding new ways to incorporate it to transform and modernize clinical trials.

Offered Free by: PPD
See All Resources from: PPD